{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Linezolid+IV", "query": { "intervention": "Linezolid IV" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 31, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Linezolid+IV&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T21:07:11.635Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01756924", "title": "Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prosthetic Joint Infections of Hip", "Prosthetic Joint Infections of Knee", "Infected Spacers" ], "interventions": [ { "name": "CEM-102", "type": "DRUG" }, { "name": "IV or Oral standard of care antibiotics", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arrevus Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2012-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2019-04-19", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 13, "location_summary": "Sarasota, Florida • Tamarac, Florida • Savannah, Georgia + 8 more", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01756924" }, { "nct_id": "NCT01400867", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections, Pediatrics" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam", "type": "DRUG" }, { "name": "Cephalexin or Clindamycin or Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": 163, "start_date": "2011-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Orange, California • San Diego, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400867" }, { "nct_id": "NCT02732327", "title": "Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neoplasms", "Febrile Neutropenia" ], "interventions": [ { "name": "CAZ-AVI", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Piperacillin/tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2016-05-17", "completion_date": "2016-06-27", "has_results": true, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02732327" }, { "nct_id": "NCT00108433", "title": "Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacteremia", "Gram-Positive Bacterial Infections" ], "interventions": [ { "name": "Cefazolin IV", "type": "DRUG" }, { "name": "Linezolid IV", "type": "DRUG" }, { "name": "Vancomycin (IV)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 61, "start_date": "2005-09", "completion_date": "2006-09", "has_results": true, "last_update_posted_date": "2012-08-07", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 3, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00108433" }, { "nct_id": "NCT02168816", "title": "Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteomyelitis" ], "interventions": [ { "name": "Intravenous Antibacterial Agent", "type": "DRUG" }, { "name": "Oral Antibacterial Agent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2014-03-19", "completion_date": "2017-02-02", "has_results": true, "last_update_posted_date": "2018-07-19", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 1, "location_summary": "Maywood, Illinois", "locations": [ { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02168816" }, { "nct_id": "NCT01570192", "title": "Clinical Trials to Reduce the Risk of Antimicrobial Resistance", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Pneumonia" ], "interventions": [ { "name": "IV meropenem", "type": "DRUG" }, { "name": "I.V. Meropenem", "type": "DRUG" }, { "name": "Parenteral aminoglycoside; tobramycin for injection USP OR gentamicin sulfate injection solution concentrate 5mg.kg IV q24h; amikacin sulfate injection USP 20 mg/kg IV q24h", "type": "DRUG" }, { "name": "Linezolid or Vancomycin (per institutional guidelines) will be available for MRSA coverage.", "type": "DRUG" }, { "name": "tobramycin nebulization", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2010-09", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2017-09-29", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 8, "location_summary": "San Mateo, California • Gainesville, Florida • Atlanta, Georgia + 5 more", "locations": [ { "city": "San Mateo", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "North Liberty", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570192" }, { "nct_id": "NCT01421511", "title": "TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Skin and Subcutaneous Tissue Bacterial Infections" ], "interventions": [ { "name": "TR-701 FA", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 666, "start_date": "2011-09-15", "completion_date": "2013-01-10", "has_results": true, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 35, "location_summary": "Dothan, Alabama • Chula Vista, California • Escondido, California + 31 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01421511" }, { "nct_id": "NCT02679573", "title": "Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community Acquired Bacterial Pneumonia" ], "interventions": [ { "name": "Delafloxacin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melinta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 860, "start_date": "2016-12-14", "completion_date": "2018-08-07", "has_results": true, "last_update_posted_date": "2020-02-27", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 25, "location_summary": "Montgomery, Alabama • Newark, Delaware • Coral Gables, Florida + 21 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Newark", "state": "Delaware" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02679573" }, { "nct_id": "NCT03176134", "title": "A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Bacterial Skin and Skin Structure Infections" ], "interventions": [ { "name": "Tedizolid phosphate", "type": "DRUG" }, { "name": "Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "11 Years", "sex": "ALL", "summary": "1 Day to 11 Years" }, "enrollment_count": 100, "start_date": "2019-01-20", "completion_date": "2023-07-06", "has_results": true, "last_update_posted_date": "2025-07-31", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 8, "location_summary": "San Diego, California • Chicago, Illinois • Detroit, Michigan + 5 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03176134" }, { "nct_id": "NCT05369052", "title": "Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Foot Infection" ], "interventions": [ { "name": "contezolid acefosamil (IV)/contezolid (PO)", "type": "DRUG" }, { "name": "Linezolid (IV and PO)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MicuRx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 865, "start_date": "2022-05-03", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-09-10", "last_synced_at": "2026-09-10T21:07:11.635Z", "location_count": 2, "location_summary": "Corona, California • Vista, California", "locations": [ { "city": "Corona", "state": "California" }, { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05369052" } ] }